50+ ways House Republicans are fighting the opioid crisis

Aug 01, 2018 | Communications •

We come from different backgrounds, hometowns, and walks of life. But, sadly, every community in this country is united in the common tragedy of opioid addiction. And that’s why we’ve taken action, making a historic $4 billion investment in this fight — the most significant congressional effort against a single drug crisis in history.

House Republicans have led on efforts to combat the opioid crisis, prioritizing treatment and recovery, prevention, ways to protect our community, and fighting fentanyl. We’ve built on the successes of the 21st Century Cures Act and the Comprehensive Addiction and Recovery Act (CARA) to make our communities safer, and America is Better Off Now than it was two years ago. For more on our work, visit Better.gopAnd be sure to tell your friends!

Here are 50+ ways House Republicans are fighting the opioid crisis:

H.R. 449 Synthetic Drug Awareness Act of 2018, as amended

  • This bill requires the U.S. Surgeon General to report to Congress on the public health effects of the rise in synthetic drug use among youth aged 12 to 18 years old in order to further educate parents and the medical community on the health effects of synthetics.

H.R. 4284- INFO Act, as amended

  •     This bill directs the Department of Health and Human Services (HHS) to create a public and easily accessible electronic dashboard linking to all of the nationwide efforts to combat the opioid crisis. In addition, the legislation creates an Interagency Substance Use Disorder Coordinating Committee to review and coordinate opioid use disorder (OUD) and other substance use disorder (SUD) research, services, and prevention activities across all relevant Federal agencies, evaluate the effectiveness of these activities, and make specific recommendations for actions that agencies can take to better coordinate the administration of services for patients with OUD and SUD.

H.R. 4684- Ensuring Access to Quality Sober Living Act of 2018, as amended

  • This bill authorizes the Substance Abuse and Mental Health Services Administration to develop, publish, and disseminate best practices for operating recovery housing that promotes a safe environment and sustained recovery from substance use disorders.

H.R. 5002- ACE Research Act

  • This bill provides the National Institutes of Health new authorities to conduct research on innovative non-addictive pain medications.

H.R. 5009-Jessie’s Law, as amended

  •     Would help ensure doctors have access to a consenting patient’s prior history of addiction in order to make fully informed decisions for care and treatment.

H.R. 5102-Substance Use Disorder Workforce Loan Repayment Act of 2018

  •     This bill creates a loan repayment program for substance use disorder (SUD) treatment providers. Specifically, the legislation offers student loan repayment of up to $250,000 for participants who agree to work as a SUD treatment professional in areas most in need of their services.

H.R. 5176-Preventing Overdoses While in Emergency Rooms Act, as amended

  • This bill requires the Secretary of the Department of Health and Human Services (HHS) to develop protocols and a grant program for health care providers to address the needs of people who survive a drug overdose. Specifically, the protocols would address the provision of naloxone upon discharge, connection with peer-support specialists, and the referral to treatment and other services that best fit the patient’s needs. The bill authorizes $50 million in FY2019 for the grant program.

H.R. 5197-ALTO Act, as amended

  •     This bill directs the Secretary of Health and Human Services (HHS) to carry out a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital emergency departments. Following the completion of the three-year demonstration, the Secretary of Health and Human Services will submit a report to Congress on the results of the program and issue recommendations for broader implementation. The legislation authorizes $10 million annually in grants for fiscal years 2019-2021.

H.R. 5261-TEACH to Combat Addiction Act of 2018, as amended

  •     This bill directs the Secretary of Health and Human Services (HHS) to designate regional Centers of Excellence to enhance and improve how health professionals are educated in substance abuse disorder prevention, treatment, and recovery through development, evaluation, and distribution of evidence-based curricula for health profession schools. The bill authorizes $4 million annually for grants to those programs over the 2019-2023 period.

H.R. 5272- Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act of 2018

  • This bill requires the newly established National Mental Health and Substance Use Policy Laboratory to issue guidance to applicants for Substance Abuse and Mental Health Services Administration (SAMHSA) grants that support evidence-based practices.                                              

H.R. 5327-Comprehensive Opioid Recovery Centers Act of 2018, as amended

  •     This bill directs the Secretary of Health and Human Services (HHS) to award grants to at least 10 providers that offer treatment services for people with opioid use disorder. These Comprehensive Opioid Recovery Centers would serve as models for comprehensive treatment and recovery and would utilize the full range of Food and Drug Administration approved medications and evidence-based treatments, have strong linkages with the community, generate meaningful outcomes data, and dramatically improve the opportunities for individuals to establish and maintain long-term recovery.

H.R. 5329- Poison Center Network Enhancement Act of 2018, as amended

  • This bill reauthorizes the national network of Poison Control Centers. Specifically, the legislation reauthorizes the toll-free number, national media campaign, and grant program under the Public Health Service Act. The legislation increases the share of poison control center funding that could be provided through federal grants, and authorizes $30 million per year over the 2019-2023 period

H.R. 5353- Eliminating Opioid-Related Infectious Diseases Act of 2018, as amended

  •     This bill authorizes the Centers for Disease Control (CDC) to undertake an injection drug-use associated infection elimination initiative and work with states to improve education, surveillance, and treatment of infections associated with injection drug use.

H.R. 5587-Peer Support Communities of Recovery Act, as amended

  • This bill enhances the Comprehensive Addiction and Recovery Act’s Building Communities of Recovery Program and authorizes the Department of Health and Human Services (HHS) to award grants to peer support specialist organizations for the development and expansion of recovery services. Grants shall be awarded to nonprofit organizations that support community-based, peer delivered support, including technical support for the establishment of recovery community organizations, independent, nonprofit groups led by people in recovery and their families.

H.R. 5812-CONNECTIONS Act

  • This bill will authorize the Centers for Disease Control and Prevention to carry out certain controlled substances overdose prevention and surveillance activities in order to improve data collection and integration into physician clinical workflow so that timely, complete, and accurate information will get into the hands of providers and dispensers so that they can make the best clinical decisions for their patients.

H.R. 5228-SCREEN Act, as amended

  •     This bill will provide the Food and Drug Administration (FDA) with stronger recall and seizure authority to disrupt the entry of counterfeit and illicit drugs through International Mail Facilities (IMFs).

H.R. 5473- Better Pain Management Through Better Data Act of 2018, as amended

  •     This bill directs the Food and Drug Administration to hold a public meeting and issue guidance to industry addressing data collection and labeling for medical products that reduce pain and may replace, delay, or reduce the use of oral opioids.

H.R. 5752- Stop Illicit Drug Importation Act of 2018, as amended

  •     This bill  amends the Federal Food, Drug, and Cosmetic Act (FD&C) to strengthen the Food and Drug Administration’s (FDA) seizure powers and enhance its authority to detain, refuse, seize, or destroy illegal products offered for import. The legislation would subject more people to debarment and civil penalties under the Act.

H.R. 5800- Medicaid IMD ADDITIONAL INFO Act

  •     This bill directs the Medicaid and CHIP Payment and Access Commission (MACPAC) to conduct a study on institutions for mental disease that receive Medicaid reimbursement. The study shall report on the requirements and standards that state Medicaid programs have in place for institutions for mental diseases (IMD). MACPAC shall summarize the findings and make recommendations on best practices and data collection no later than January 2020.

H.R. 5583- To amend title XI of the Social Security Act to require States to annually report on certain adult health quality measures, and for other purposes

  •     This bill requires states to include behavioral health indicators in their annual reports on the quality of care under Medicaid beginning in 2024.

H.R. 3331- To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology, as amended

  •     This bill authorizes the Center for Medicare and Medicaid Innovation to test a program offering incentive payments to behavioral health providers that adopt and use certified electronic health record technology.

H.R. 5582- Abuse Deterrent Access Act of 2018, as amended

  •     This bill requires the Secretary of the Department of Health and Human Services (HHS) to report to Congress on existing barriers to access to “abuse-deterrent opioid formulations” by Medicare Part C and D beneficiaries.

H.R. 5685- Medicare Opioid Safety Education Act of 2018

  • This bill requires the Centers for Medicare & Medicaid Services to provide Medicare beneficiaries with educational resources regarding opioid use and pain management, as well as descriptions of covered alternative (non-opioid) pain-management treatments.

H.R. 4275- Empowering Pharmacists in the Fight Against Opioid Abuse Act, as amended

  • This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

H.R. 5041- Safe Disposal of Unused Medication Act, as amended

  • An Act to amend the Controlled Substances Act to authorize the employees of a hospice program to handle controlled substances lawfully in the possession of a deceased hospice patient for the purpose of disposal.

H.R. 5202- Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

  • H.R. 5202 would allow pharmacists to dispense medication-assisted treatments to doctors, rather than directly to patients, in an attempt to improve dispensing of implantable and injectable therapies developed to make abuse, misuse, and diversion more difficult.

H.R. 5483 Special Registration for Telemedicine Clarification Act of 2018, as amended

  • Amends the Controlled Substances Act to establish a deadline for the Drug Enforcement Administration to promulgate regulations for the special registration of practitioners to practice telemedicine.

H.R. 5294 Treating Barriers to Prosperity Act of 2018

  •     This bill allows the Appalachian Regional Commission to support projects and activities addressing drug abuse, including opioid abuse.

H.R. 6029 REGROUP Act of 2018

  •     Reauthorizes the comprehensive opioid abuse grant program, and for other purposes.

H.R. 2147 – Veterans Treatment Court Improvement Act of 2018, as amended

  • This bill requires the Department of Veterans Affairs (VA) to hire at least 50 Veterans Justice Outreach Specialists under the Veterans Justice Outreach Program. Each of these specialists must serve as part of a justice team in a veterans treatment court or other veteran-focused court.

H.R. 4635 To direct VA to increase the number of peer-to-peer counselors providing counseling for women veterans, and for other purposes, as amended

  •     This bill directs the Department of Veterans Affairs (VA) to emphasize appointing peer support counselors for women veterans. The VA shall recruit women peer support counselors with expertise in gender-specific issues and services, VA services and benefits, and employment mentoring.

H.R. 5892 To establish an Advisory Committee on Opioids and the Workplace to advise the Secretary of Labor on actions the Department of Labor can take to address the impact of opioid abuse on the workplace

  • This bill would create an Advisory Committee to advise the Secretary of Labor on actions the Department can take to address the impact of opioid abuse on the workplace.

1091 – Supporting Grandparents Raising Grandchildren Act (House amendment)

  •     The bill establishes an Advisory Council to Support Grandparents Raising Grandchildren.

H.R. 5890 — the Assisting States’ Implementation of Plans of Safe Care Act

  •   The bill requires HHS to provide states with guidance to support their implementation of the plans of safe care assurance, including by enhancing their understanding of the law, addressing state-identified challenges, sharing best practices, and supporting collaboration.

H.R. 2851 Stop the Importation and Trafficking of Synthetic Analogues Act of 2017

  •     This bill outlaws 13 different synthetic drugs of the most pernicious varieties, by creating a new “schedule” (a term for “categorization”) to the list of banned substances on the Controlled Substances Act.

H.R. 5788 Synthetics Trafficking and Overdose Prevention Act of 2018

  •     This bill would require the U.S. Postal Service (USPS) to transmit advance electronic data (AED) to Customs and Border Protection (CBP) on at least 70 percent of international packages by December 31, 2018, and 100 percent of international packages by December 31, 2020. The data will enable CBP to target high-risk shipments for inspection and seizure. The bill would require USPS to refuse shipments for which AED is not furnished after December 31, 2020 or to take remedial measures, including law enforcement actions, to ensure compliance.

H.R. 3192 – CHIP Mental Health Parity Act, as amended

  •     Works to ensure access to mental health services for children under the Children’s Health Insurance Program, and for other purposes.

H.R. 4005 – Medicaid Reentry Act, as amended

  • Allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual’s release.

H.R. 5590 – Opioid Addiction Action Plan Act

  • This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop an action plan to provide recommendations on changes to the Medicare and Medicaid programs to enhance: (1) the treatment and prevention of opioid addiction, and (2) the coverage and reimbursement of medication-assisted treatment for opioid addiction.

H.R. 5687–SOUND Disposal and Packaging Act, as amended

  •         The bill will direct the Food and Drug Administration (FDA) to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids.

H.R. 5605 – Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act, as amended

  • This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access of opioid use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.

H.R. 5796 – REACH OUT Act of 2018, as amended

  •     This bill requires the Centers for Medicare & Medicaid Services to award grants, contracts, or cooperative agreements to qualifying organizations in order to support efforts to curb outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans.

H.R. 5801 – Medicaid PARTNERSHIP Act, as amended

  • This bill seeks to amend title XIX of the Social Security Act to provide for requirements under the Medicaid program relating to the use of qualified prescription drug monitoring programs and prescribing certain controlled substances.

H.R. 6042- To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes, as amended

  • Delays the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes pertaining to residents of hospitals and care facilities.

H.R. 5773- PASS Act of 2018, as amended

  •   Requires Medicare prescription drug plans to establish drug management programs for at-risk beneficiaries, require electronic prior authorization for covered part D drugs, and to provide for other program integrity measures under parts C and D of the Medicare program.

H.R. 5676- SENIOR Communities Protection Act of 2018, as amended

  • This bill authorizes the suspension of payments to a pharmacy under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans pending the investigation of a credible allegation of fraud by the pharmacy. A fraud hotline tip, without other evidence, may not be considered a credible allegation of fraud.

H.R. 5723- Expanding Oversight of Opioid Prescribing and Payment Act of 2018, as amended

  •     This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

H.R. 5774- COACH Act of 2018, as amended

  • This bill requires the Centers for Medicare & Medicaid Services to: (1) publish guidance for hospitals on pain management and opioid-use disorder prevention strategies for Medicare beneficiaries, (2) convene a technical expert panel to recommend opioid and opioid-use disorder quality measures for possible use in hospital payment and reporting models under Medicare, and (3) publish and periodically update all guidance issued since January 1, 2016 related to the prescription of opioids for Medicare beneficiaries.

H.R. 5775- Providing Reliable Options for Patients and Educational Resources Act of 2018

  •     Requires Medicare Advantage plans and part D prescription drug plans to include information on the risks associated with opioids, coverage of certain non-opioid treatments used to treat pain, and on the safe disposal of prescription drugs, and for other purposes.

H.R. 6110 – Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

  •     A bill to direct the Secretary of Health and Human Services to conduct a study and submit to Congress a report containing recommendation on how to improve the use of non-opioid treatments for acute and chronic pain management for individuals entitled to benefits under part A or enrolled under part B of the Medicare program.

H.R. 5762 – Joint Task Force to Combat Opioid Trafficking Act of 2018, as amended

  • Authorizes a Joint Task Force to enhance integration of the Department of Homeland Security’s border security operations to detect, interdict, disrupt, and prevent narcotics, such as fentanyl and other synthetic opioids, from entering the United States.

H.R. 5797- Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Delivery Act (as reported)

  • This bill temporarily allows states to apply to receive federal Medicaid payment for services provided in institutions for mental diseases (IMDs) and for other medically necessary services for enrollees (aged 21 to 64) with opioid use disorders. Services may be covered for a total of up to 30 days in a 12-month period for an eligible enrollee. States must include specified information in their applications, including plans to improve access to outpatient care.

H.R. 6082- Overdose Prevention and Patient Safety Act

  •   This bill amends the Public Health Service Act to align federal privacy standards for substance use disorder (SUD) patient records more closely with standards under the Health Insurance Portability and Accountability Act (HIPAA). Specifically, the bill authorizes the disclosure of SUD patient records without a patient’s written consent to: (1) a covered entity for the purposes of treatment, payment, and health care operations, as long as the disclosure is made in accordance with HIPAA; and (2) a public health authority, as long as the content of the disclosure meets HIPAA standards regarding de-identified information. Current law authorizes disclosure of SUD patient records without a patient’s written consent only to medical personnel in a medical emergency, to specified personnel for research or program evaluations, or pursuant to a court order.

H.R. 6- Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act(Rules Committee Print 115-76—Showing the text of H.R. 6, as introduced)

  •     This bill includes numerous bills to improve prevention and public health efforts, enhance treatment and recovery programs, provide communities more tools to counter opioid abuse, and bolster efforts to fight deadly illicit synthetic drugs like Fentanyl.

H.R. 5811 – Long-Term Opioid Efficacy Act of 2018

  • This bill seeks to amend the Federal Food, Drug, and Cosmetic Act with respect to post approval study requirements for certain controlled substances.

H.R. 5735 — Transitional Housing for Recovery in Viable Environments Demonstration Program Act

  • The bill establishes a five-year demonstration program to support transitional housing for individuals recover­ing from opioid addiction. The bill sets aside 10,000 Section 8 housing vouchers specifically for people with an opioid use disorder. The vouchers would only be available for people in programs that provide opioid abuse and substance abuse treatment and job skills training according to standards established by the HUD Secretary.

H.R. 5483 — Special Registration for Telemedicine Clarification Act of 2018

  • The bill will clarify telemedicine waivers. Federal law permits the Attorney General to issue a special registra­tion to health care providers to prescribe controlled substances via telemedicine in legitimate emergency situations, such as a lack of access to an in-person specialist.

H.R. 5891 — Improving the Federal Response to Families Impacted by Substance Use Disorder Act

  •     The bill establishes an interagency task force to develop a strategy on how federal agencies can implement a coordinated approach to responding to the opioid epidemic, with a particular focus on the existing programs that support infants, children, and their families.